Newsroom

Industry News

21 Sep

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

Presentation with live webcast on Wednesday, September 27 at 1:00 p.m. ET ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the 2017 Disruptive Growth Company Showcase NYC, presented by SeeThruEquity and RHK...

Read more

21 Sep

Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies

PLYMOUTH MEETING, Pa., Sept. 21, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific papers that demonstrate their impact on prostate tumors and in preventing infection from a pneumonia-causing bacteria in preclinical...

Read more

21 Sep

Arkados Group Inc. Reports 2017 Fiscal Year End Financial Results and Announces Corporate Re-Branding to Solbright Group, Inc.

NEWARK, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) — Arkados Group, Inc. (AKDS), an industrial automation and energy management company providing Industrial Internet of Things (IoT) solutions that help commercial and industrial facilities increase efficiency and reduce cost, today announced the corporate re-branding of the Company to Solbright Group, Inc....

Read more

20 Sep

CLR Roasters Announces 419 Percent Increase in August Unit Sales Driven by Ad Specials for Cafe La Rica Brand

MIAMI, FL–(Marketwired – Sep 20, 2017) – CLR Roasters, a wholly owned subsidiary of Youngevity International, Inc. ( NASDAQ : YGYI ) and makers of Café La Rica espresso, “The OfficalCafecito of the Miami Marlins,” today announced a Four Hundred and Nineteen percent increase in unit sales for the month of August. Management at CLR Roasters...

Read more

20 Sep

Ascent Solar Reaches Extension Agreement with Investor to Restructure Existing Promissory Notes

THORNTON, CO–(Marketwired – Sep 20, 2017) – Ascent Solar Technologies, Inc. ( OTC PINK : ASTI ), a developer and manufacturer of state-of-the-art, flexible thin-film photovoltaic (PV) solutions, announced that the Company has entered into a Promissory Note Exchange Agreement (“Agreement”) with investor (“Investor”) to restructure and extend the maturity of the existing Promissory Notes....

Read more

18 Sep

OncoCyte Reports Positive Analytical Validation Study Results of DetermaVu™ Lung Cancer Diagnostic Test

ALAMEDA, Calif., Sept. 18, 2017 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive blood-based liquid biopsy tests to assist in the early detection of cancer, announced today positive final results from the Analytical Validation Study of its liquid biopsy lung cancer diagnostic test, DetermaVU™. The data were...

Read more

18 Sep

CymaBay Therapeutics to Present at Two Investor Conferences

NEWARK, Calif., Sept. 18, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need, today announced that management will provide a corporate overview at the Cantor Fitzgerald Global Healthcare Conference, and the...

Read more

15 Sep

Ascent Solar Technologies, Inc. Secures Additional Funding

THORNTON, CO–(Marketwired – Sep 15, 2017) – Ascent Solar Technologies, Inc. ( OTCQB : ASTI ), a developer and manufacturer of state-of-the-art, flexible thin-film photovoltaic (PV) solutions, announced that the Company has entered into a Securities Purchase Agreement (“Agreement”) with a new investor (“Investor”) for the private placement of $1.725 Million of a newly designated...

Read more

Page 1 of 25512345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address